Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Chubb
Deloitte
Johnson and Johnson
US Department of Justice
Cerilliant
Julphar
Cantor Fitzgerald
Federal Trade Commission

Generated: October 20, 2018

DrugPatentWatch Database Preview

Tazarotene - Generic Drug Details

« Back to Dashboard

What are the generic sources for tazarotene and what is the scope of tazarotene patent protection?

Tazarotene is the generic ingredient in four branded drugs marketed by Mayne Pharma, Allergan, G And W Labs Inc, and Taro Pharms, and is included in five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for tazarotene. Five suppliers are listed for this compound.

Pharmacology for tazarotene
Ingredient-typeRetinoids
Drug ClassRetinoid
Synonyms for tazarotene
118292-40-3
15146-EP2275420A1
15146-EP2295055A2
15146-EP2295416A2
15146-EP2298748A2
15146-EP2298764A1
15146-EP2298765A1
15146-EP2298768A1
15146-EP2305642A2
15146-EP2308861A1
15146-EP2311453A1
15146-EP2311808A1
15146-EP2311829A1
15146-EP2314590A1
15146-EP2316832A1
15146-EP2316833A1
292T403
3-Pyridinecarboxylic acid, 6-((3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl)-, ethyl ester
3-Pyridinecarboxylic acid, 6-((3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl)-,ethyl ester
4CA-1215
6-(4,4-Dimethyl-thiochroman-6-ylethynyl)-nicotinic acid ethyl ester
6-(4,4-dimethylthiochroman-6-ylethynyl) nicotinic acid ethyl ester
6-[(3,4-Dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]-3-pyridinecarboxylic acid ethyl ester
6-[2-(3,4-Dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]- 3-pyridinecarboxylic Acid Ethyl Ester
6-[2-(3,4-Dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]-3-pyridinecarboxylic acid ethyl ester
6-[2-(3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]-3-pyridinecarboxylicacidethylester
81BDR9Y8PS
AB0012671
AB01274801_02
AB01274801-01
AB2000146
ABP000994
AC-755
AC1L1K88
Acnitaz
ACT06773
AGN 190168
AGN-190168
AJ-26850
AK-73028
AKOS015902872
AN-15540
ANW-45265
Avage
Avage (TN)
AX8041205
BC201578
BCP0726000163
BDBM50265951
BIDD:GT0293
BR-73028
BS-1012
C-23771
C12531
C21H21NO2S
CAS-118292-40-3
CC-34651
CHEBI:32184
CHEMBL1657
CJ-24315
CS-1029
CTK8B4490
D01132
D0BM5G
DB00799
DR001785
DSSTox_CID_26691
DSSTox_GSID_46691
DSSTox_RID_81825
DTXSID5046691
EBD38650
Ethyl 6-((4,4-dimethylthiochroman-6-yl)ethynyl)nicotinate
Ethyl 6-((4,4-dimethylthiochroman-6-yl)ethynyl)nicotinate;6-(4,4-dimethyl-thiochroman-6-ylethynyl)-nicotinic acid ethyl ester
ethyl 6-(2-(4,4-dimethylthiochroman-6-yl)-ethynyl)nicotinate
ethyl 6-(2-(4,4-dimethylthiochroman-6-yl)ethynyl)nicotinate
ethyl 6-[(4,4-dimethyl-3,4-dihydro-2H-thiochromen-6-yl)ethynyl]nicotinate
Ethyl 6-[(4,4-dimethyl-3,4-dihydro-2H-thiochromen-6-yl)ethynyl]pyridine-3-carboxylate
ethyl 6-[2-(4,4-dimethyl-2,3-dihydrothiochromen-6-yl)ethynyl]pyridine-3-carboxylate
ethyl 6-[2-(4,4-dimethyl-3,4-dihydro-2H-1-benzothiopyran-6-yl)ethynyl]pyridine-3-carboxylate
Ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)-ethynyl]nicotinate
ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)ethynyl] nicotinate
Ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)ethynyl]nicotinate
ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)ethynyl]pyridine-3-carboxylate
Fabior
Fabior (TN)
FT-0652578
GTPL6952
HE299896
HMS3655K05
HY-15388
I14-1992
KB-80817
LS-130838
MFCD00867628
MLS003915630
MolPort-005-932-693
NCGC00167525-01
NCGC00167525-02
NCGC00167525-03
OGQICQVSFDPSEI-UHFFFAOYSA-N
PubChem24431
Q-102516
RTR-034197
S-7551
s1569
SC-19506
SCHEMBL3134
SMR002096194
SR-01000931253
SR-01000931253-2
ST2419369
Suretin
Tazarotene (Avage)
Tazarotene (JAN/USAN/INN)
Tazarotene [USAN:INN:BAN]
Tazarotene [USAN:INN]
tazaroteno
tazarotenum
Tazorac
Tazorac (TN)
Tazorac, Avage, Zora, Tazarotene
Tazorac;Avage;Zora;Avage
Tazoral
Tox21 112522
Tox21_112522
Tox21_112522_1
TR-034197
UNII-81BDR9Y8PS
ZINC1542199
Zora
Zorac
Zorac (TN)
Zorac|||Tazorac

US Patents and Regulatory Information for tazarotene

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan TAZORAC tazarotene GEL;TOPICAL 020600-001 Jun 13, 1997 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mayne Pharma FABIOR tazarotene AEROSOL, FOAM;TOPICAL 202428-001 May 11, 2012 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Taro Pharms TAZAROTENE tazarotene CREAM;TOPICAL 208258-001 Apr 3, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Allergan TAZORAC tazarotene CREAM;TOPICAL 021184-001 Sep 29, 2000 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for tazarotene

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan TAZORAC tazarotene GEL;TOPICAL 020600-001 Jun 13, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan AVAGE tazarotene CREAM;TOPICAL 021184-003 Sep 30, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan TAZORAC tazarotene GEL;TOPICAL 020600-002 Jun 13, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan TAZORAC tazarotene GEL;TOPICAL 020600-002 Jun 13, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for tazarotene

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0008 Belgium ➤ Try a Free Trial PRODUCT NAME: TAZAROTENE; NAT. REGISTRATION NO/DATE: NL22604 19970922; FIRST REGISTRATION: DE - 37393.00.00 19961203
/1998 Austria ➤ Try a Free Trial PRODUCT NAME: TAZAROTENE; NAT. REGISTRATION NO/DATE: 1-22102, 1-22103 19970918; FIRST REGISTRATION: DE 37393.00.00, 37393.01.00 19961203
C/GB98/002 United Kingdom ➤ Try a Free Trial PRODUCT NAME: TAZAROTENE : ETHYL 6-(2-(4,4-DIMETHYLTHIOCHROMAN-6-YL) ETHYNYL) NICOTINOATE; REGISTERED: DE 37393.00.00 19961203; DE 37393.01.00 19961203; UK 00426/0097 19970730; UK 00426/0096 19970730
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Chubb
Deloitte
Johnson and Johnson
US Department of Justice
Cerilliant
Julphar
Cantor Fitzgerald
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

if (!strstr($_SERVER['REQUEST_URI'],'/subs/')) { if (strstr($_SERVER['REQUEST_URI'],'/subscribe') || ($_SERVER['HTTP_CF_IPCOUNTRY'] != 'IN' && $_SERVER['HTTP_CF_IPCOUNTRY'] != 'CN')) { echo <<< EOF EOF; } }